![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC39A14 |
Gene summary for SLC39A14 |
![]() |
Gene information | Species | Human | Gene symbol | SLC39A14 | Gene ID | 23516 |
Gene name | solute carrier family 39 member 14 | |
Gene Alias | HCIN | |
Cytomap | 8p21.3 | |
Gene Type | protein-coding | GO ID | GO:0000041 | UniProtAcc | Q15043 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23516 | SLC39A14 | HTA11_347_2000001011 | Human | Colorectum | AD | 4.10e-07 | 4.16e-01 | -0.1954 |
23516 | SLC39A14 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.02e-05 | 7.12e-01 | -0.059 |
23516 | SLC39A14 | A015-C-203 | Human | Colorectum | FAP | 4.58e-10 | -1.92e-01 | -0.1294 |
23516 | SLC39A14 | A015-C-204 | Human | Colorectum | FAP | 4.24e-05 | -2.81e-01 | -0.0228 |
23516 | SLC39A14 | A014-C-040 | Human | Colorectum | FAP | 4.17e-02 | -3.46e-01 | -0.1184 |
23516 | SLC39A14 | A002-C-201 | Human | Colorectum | FAP | 8.32e-07 | -2.35e-01 | 0.0324 |
23516 | SLC39A14 | A001-C-108 | Human | Colorectum | FAP | 9.30e-07 | -2.40e-01 | -0.0272 |
23516 | SLC39A14 | A002-C-205 | Human | Colorectum | FAP | 1.60e-10 | -2.47e-01 | -0.1236 |
23516 | SLC39A14 | A015-C-005 | Human | Colorectum | FAP | 6.21e-05 | -2.80e-01 | -0.0336 |
23516 | SLC39A14 | A015-C-006 | Human | Colorectum | FAP | 3.45e-08 | -3.03e-01 | -0.0994 |
23516 | SLC39A14 | A015-C-106 | Human | Colorectum | FAP | 2.01e-06 | -2.03e-01 | -0.0511 |
23516 | SLC39A14 | A002-C-114 | Human | Colorectum | FAP | 1.23e-08 | -2.08e-01 | -0.1561 |
23516 | SLC39A14 | A015-C-104 | Human | Colorectum | FAP | 7.45e-13 | -2.96e-01 | -0.1899 |
23516 | SLC39A14 | A001-C-014 | Human | Colorectum | FAP | 6.11e-05 | -2.32e-01 | 0.0135 |
23516 | SLC39A14 | A002-C-016 | Human | Colorectum | FAP | 1.15e-09 | -2.23e-01 | 0.0521 |
23516 | SLC39A14 | A015-C-002 | Human | Colorectum | FAP | 5.12e-04 | -2.21e-01 | -0.0763 |
23516 | SLC39A14 | A001-C-203 | Human | Colorectum | FAP | 3.61e-02 | -1.80e-01 | -0.0481 |
23516 | SLC39A14 | A002-C-116 | Human | Colorectum | FAP | 5.17e-11 | -1.93e-01 | -0.0452 |
23516 | SLC39A14 | A014-C-008 | Human | Colorectum | FAP | 5.61e-07 | -3.22e-01 | -0.191 |
23516 | SLC39A14 | A018-E-020 | Human | Colorectum | FAP | 3.74e-09 | -2.31e-01 | -0.2034 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0032868 | Colorectum | AD | response to insulin | 91/3918 | 264/18723 | 2.02e-07 | 8.48e-06 | 91 |
GO:1901653 | Colorectum | AD | cellular response to peptide | 114/3918 | 359/18723 | 8.32e-07 | 2.88e-05 | 114 |
GO:0009743 | Colorectum | AD | response to carbohydrate | 86/3918 | 253/18723 | 8.43e-07 | 2.90e-05 | 86 |
GO:0032869 | Colorectum | AD | cellular response to insulin stimulus | 72/3918 | 203/18723 | 1.10e-06 | 3.68e-05 | 72 |
GO:0071375 | Colorectum | AD | cellular response to peptide hormone stimulus | 95/3918 | 290/18723 | 1.50e-06 | 4.66e-05 | 95 |
GO:0055076 | Colorectum | AD | transition metal ion homeostasis | 53/3918 | 138/18723 | 1.89e-06 | 5.65e-05 | 53 |
GO:0043434 | Colorectum | AD | response to peptide hormone | 126/3918 | 414/18723 | 2.70e-06 | 7.86e-05 | 126 |
GO:0034284 | Colorectum | AD | response to monosaccharide | 76/3918 | 225/18723 | 4.64e-06 | 1.23e-04 | 76 |
GO:0033500 | Colorectum | AD | carbohydrate homeostasis | 84/3918 | 259/18723 | 9.10e-06 | 2.15e-04 | 84 |
GO:0009746 | Colorectum | AD | response to hexose | 73/3918 | 219/18723 | 1.20e-05 | 2.65e-04 | 73 |
GO:0009749 | Colorectum | AD | response to glucose | 71/3918 | 212/18723 | 1.31e-05 | 2.85e-04 | 71 |
GO:0042593 | Colorectum | AD | glucose homeostasis | 83/3918 | 258/18723 | 1.44e-05 | 3.11e-04 | 83 |
GO:0001678 | Colorectum | AD | cellular glucose homeostasis | 60/3918 | 172/18723 | 1.49e-05 | 3.18e-04 | 60 |
GO:0019318 | Colorectum | AD | hexose metabolic process | 77/3918 | 237/18723 | 1.96e-05 | 4.01e-04 | 77 |
GO:0046916 | Colorectum | AD | cellular transition metal ion homeostasis | 43/3918 | 115/18723 | 3.62e-05 | 6.56e-04 | 43 |
GO:0071322 | Colorectum | AD | cellular response to carbohydrate stimulus | 56/3918 | 163/18723 | 4.61e-05 | 7.97e-04 | 56 |
GO:0005996 | Colorectum | AD | monosaccharide metabolic process | 80/3918 | 257/18723 | 7.31e-05 | 1.17e-03 | 80 |
GO:0071333 | Colorectum | AD | cellular response to glucose stimulus | 52/3918 | 151/18723 | 7.88e-05 | 1.25e-03 | 52 |
GO:0071331 | Colorectum | AD | cellular response to hexose stimulus | 52/3918 | 153/18723 | 1.16e-04 | 1.71e-03 | 52 |
GO:0071326 | Colorectum | AD | cellular response to monosaccharide stimulus | 52/3918 | 154/18723 | 1.40e-04 | 1.98e-03 | 52 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0501214 | Liver | Cirrhotic | Parkinson disease | 158/2530 | 266/8465 | 3.62e-24 | 6.02e-22 | 3.71e-22 | 158 |
hsa0501014 | Liver | Cirrhotic | Alzheimer disease | 180/2530 | 384/8465 | 5.52e-13 | 1.36e-11 | 8.36e-12 | 180 |
hsa0421621 | Liver | Cirrhotic | Ferroptosis | 23/2530 | 41/8465 | 4.09e-04 | 2.57e-03 | 1.58e-03 | 23 |
hsa0501215 | Liver | Cirrhotic | Parkinson disease | 158/2530 | 266/8465 | 3.62e-24 | 6.02e-22 | 3.71e-22 | 158 |
hsa0501015 | Liver | Cirrhotic | Alzheimer disease | 180/2530 | 384/8465 | 5.52e-13 | 1.36e-11 | 8.36e-12 | 180 |
hsa0421631 | Liver | Cirrhotic | Ferroptosis | 23/2530 | 41/8465 | 4.09e-04 | 2.57e-03 | 1.58e-03 | 23 |
hsa0501222 | Liver | HCC | Parkinson disease | 198/4020 | 266/8465 | 9.40e-20 | 1.58e-17 | 8.76e-18 | 198 |
hsa0501022 | Liver | HCC | Alzheimer disease | 254/4020 | 384/8465 | 3.75e-14 | 8.97e-13 | 4.99e-13 | 254 |
hsa0421641 | Liver | HCC | Ferroptosis | 33/4020 | 41/8465 | 1.42e-05 | 9.88e-05 | 5.50e-05 | 33 |
hsa0501232 | Liver | HCC | Parkinson disease | 198/4020 | 266/8465 | 9.40e-20 | 1.58e-17 | 8.76e-18 | 198 |
hsa0501032 | Liver | HCC | Alzheimer disease | 254/4020 | 384/8465 | 3.75e-14 | 8.97e-13 | 4.99e-13 | 254 |
hsa0421651 | Liver | HCC | Ferroptosis | 33/4020 | 41/8465 | 1.42e-05 | 9.88e-05 | 5.50e-05 | 33 |
hsa0501230 | Oral cavity | OSCC | Parkinson disease | 188/3704 | 266/8465 | 1.82e-19 | 1.52e-17 | 7.75e-18 | 188 |
hsa0501028 | Oral cavity | OSCC | Alzheimer disease | 244/3704 | 384/8465 | 1.18e-15 | 3.60e-14 | 1.83e-14 | 244 |
hsa0421620 | Oral cavity | OSCC | Ferroptosis | 29/3704 | 41/8465 | 4.26e-04 | 1.30e-03 | 6.60e-04 | 29 |
hsa05012113 | Oral cavity | OSCC | Parkinson disease | 188/3704 | 266/8465 | 1.82e-19 | 1.52e-17 | 7.75e-18 | 188 |
hsa05010112 | Oral cavity | OSCC | Alzheimer disease | 244/3704 | 384/8465 | 1.18e-15 | 3.60e-14 | 1.83e-14 | 244 |
hsa04216110 | Oral cavity | OSCC | Ferroptosis | 29/3704 | 41/8465 | 4.26e-04 | 1.30e-03 | 6.60e-04 | 29 |
hsa0501262 | Oral cavity | NEOLP | Parkinson disease | 78/1112 | 266/8465 | 1.34e-12 | 1.06e-10 | 6.68e-11 | 78 |
hsa0501062 | Oral cavity | NEOLP | Alzheimer disease | 97/1112 | 384/8465 | 3.97e-11 | 1.57e-09 | 9.89e-10 | 97 |
Page: 1 2 3 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC39A14 | SNV | Missense_Mutation | novel | c.92N>T | p.Ser31Leu | p.S31L | Q15043 | protein_coding | tolerated_low_confidence(0.32) | benign(0) | TCGA-BH-A0B6-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SLC39A14 | SNV | Missense_Mutation | c.1357N>G | p.Gln453Glu | p.Q453E | Q15043 | protein_coding | tolerated(0.08) | benign(0.003) | TCGA-C8-A132-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
SLC39A14 | SNV | Missense_Mutation | novel | c.923G>A | p.Gly308Asp | p.G308D | Q15043 | protein_coding | tolerated(0.31) | benign(0.014) | TCGA-D8-A73W-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | tamoxiphen | PD |
SLC39A14 | insertion | Nonsense_Mutation | novel | c.1439_1440insACTCCAGAGGCTTTAGGGACGACGTAG | p.Val480_Val481insLeuGlnArgLeuTerGlyArgArgArg | p.V480_V481insLQRL*GRRR | Q15043 | protein_coding | TCGA-A2-A0CT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | cytoxan | SD | ||
SLC39A14 | insertion | Nonsense_Mutation | novel | c.1329_1330insGTGGCCTAACCACCATTTCTTAACGATTAAATAGATAATTTAAA | p.Met444ValfsTer3 | p.M444Vfs*3 | Q15043 | protein_coding | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SLC39A14 | insertion | Frame_Shift_Ins | novel | c.718_719insCAGACTGGAGTGCAGTGGTGCCATCTCGGCTCAC | p.Ile240ThrfsTer18 | p.I240Tfs*18 | Q15043 | protein_coding | TCGA-BH-A0DP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD | ||
SLC39A14 | SNV | Missense_Mutation | novel | c.1179N>C | p.Met393Ile | p.M393I | Q15043 | protein_coding | deleterious(0.01) | probably_damaging(0.996) | TCGA-HM-A4S6-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | CR |
SLC39A14 | SNV | Missense_Mutation | novel | c.125N>T | p.Ser42Phe | p.S42F | Q15043 | protein_coding | deleterious(0.01) | benign(0.01) | TCGA-PN-A8MA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
SLC39A14 | SNV | Missense_Mutation | novel | c.763N>A | p.His255Asn | p.H255N | Q15043 | protein_coding | deleterious(0.01) | probably_damaging(0.992) | TCGA-VS-A9UD-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR |
SLC39A14 | SNV | Missense_Mutation | novel | c.1096G>T | p.Gly366Cys | p.G366C | Q15043 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
23516 | SLC39A14 | TRANSPORTER | nortriptyline | NORTRIPTYLINE | 20970119 |
Page: 1 |